middle.news
How Will Genetic Technologies Navigate Its DOCA and Cash Crunch?
12:52pm on Monday 30th of March, 2026 AEDT
•
Healthcare
Read Story
How Will Genetic Technologies Navigate Its DOCA and Cash Crunch?
12:52pm on Monday 30th of March, 2026 AEDT
Key Points
Company under voluntary administration since November 2024
Deed of Company Arrangement executed in March 2025
Sale of geneType business to Rhythm Biosciences for $625,000 plus GST
Net operating cash outflow of $1.241 million in the quarter
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
GENETIC TECHNOLOGIES (ASX:GTG)
OPEN ARTICLE